Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma

Bortezomib-dexamethasone is widely used for relapsed myeloma in routine clinical practice, but comparative data versus single-agent bortezomib are lacking. This retrospective analysis compared second-line treatment with bortezomib-dexamethasone and bortezomib using 109 propensity score-matched pairs...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: Dimopoulos, Meletios A., Orlowski, Robert Z., Facon, Thierry, Sonneveld, Pieter, Anderson, Kenneth C., Beksac, Meral, Benboubker, Lotfi, Roddie, Huw, Potamianou, Anna, Couturier, Catherine, Feng, Huaibao, Ataman, Ozlem, van de Velde, Helgi, Richardson, Paul G.
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2015
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4281322/
https://ncbi.nlm.nih.gov/pubmed/25261096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.112037
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados